Research

This research by a team of OHE and IHE researchers estimates the value added by second generation antipsychotics over their life-cycle in the UK and Sweden. It concludes that considering the entire life-cycle, the value added by SGAs to the system is higher than the expected value estimated at launch. P&R decisions should consider the value added by medicines over the long-run.

Meet some of the OHE team at the International Health Economics Association (iHEA) 2019 World Congress in Basel, 13-17 July.

OHE staff recently attended the ISPOR annual conference in New Orleans. In this blog post, we share a selection of our presentations.

Meet some of the OHE team at the Health Technology Assessment International (HTAi) 2019 annual meeting in Cologne, 15-19 June.

Meet some of the OHE team at the Spanish Health Economics Association (AES) 2019 conference in Albacete, 12-14 June.

In collaboration with University of Technology Sydney, we’re leading a study funded by the EuroQol Research Foundation to develop ‘bolt-on’ descriptors for the EQ-5D. The goal is to develop and test new questions that can be used with people who have cognitive impairment or visual impairment.

Meet some of the OHE team at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 2019 conference in New Orleans, 18-22 May.

The Student Mental Health Research Network (SMaRteN), in which OHE is a collaborator, is conducting research to find out which outcome measures are most useful in the context of student wellbeing.

A new paper by OHE and Health Education England on the value of international volunteers’ experience to the NHS has been published in Globalization and Heath.

Koonal Shah gave a webinar for the International Health Economics Association on the topic of adult versus adolescent preferences for EQ-5D-Y health states.

Pages

Subscribe to RSS - Research